Importer of Controlled Substances; Notice of Registration, 44861 [E7-15515]
Download as PDF
<![CDATA[
44861
Federal Register / Vol. 72, No. 153 / Thursday, August 9, 2007 / Notices
basic classes of controlled substances
listed in schedule II:
Drug
Schedule
Lisdexamfetamine (1205) .............
Remifentanil (9739) ......................
II
II
The company plans to manufacture
the listed controlled substances in bulk
for sale to its customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such substances
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a). Any
such comments or objections being sent
via regular mail should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), Washington, DC 20537; or any
being sent via express mail should be
sent to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than October 9, 2007.
and determined that the registration of
Noramco, Inc. to import the basic
classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated
Noramco, Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: August 1, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–15514 Filed 8–8–07; 8:45 am]
Dated: July 31, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–15499 Filed 8–8–07; 8:45 am]
BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
Importer of Controlled Substances;
Notice of Registration
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated April 17, 2007 and
published in the Federal Register on
April 30, 2007, (72 FR 21298), Noramco
Inc., 500 Swedes Landing Road,
Wilmington, Delaware 19801, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the basic
classes of controlled substances listed in
schedule II:
Schedule
mstockstill on PROD1PC66 with NOTICES
Raw Opium (9600) .......................
Concentrate of Poppy Staw
(9670).
II
II
The company plans to import the
listed controlled substances to
manufacture other controlled
substances.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
VerDate Aug<31>2005
18:25 Aug 08, 2007
Jkt 211001
Dated: July 31, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–15515 Filed 8–8–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
DEPARTMENT OF JUSTICE
Drug
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated Penick
Corporation to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to Title 21, U.S.C.
952(a) and 958(a), and in accordance
with Title 21, Code of Federal
Regulations (CFR) § 1301.34, the above
named company is granted registration
as an importer of the basic classes of
controlled substances listed.
By Notice dated May 10, 2007 and
published in the Federal Register on
May 18, 2007, (72 FR 28077), Penick
Corporation, 33 Industrial Park Road,
Pennsville, New Jersey 08070, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the basic
classes of controlled substances listed in
schedule II:
Drug
Schedule
Coca Leaves (9040) .....................
Raw Opium (9600) .......................
Poppy Straw (9650) .....................
Concentrate of Poppy Straw
(9670).
II
II
II
II
The company plans to import the
listed controlled substances to
manufacture bulk controlled substance
intermediates for sale to its customers.
No comments or objections have been
received. DEA has considered the
factors in Title 21, United States Code
(U.S.C.) § 823(a) and § 952(a) and
determined that the registration of
Penick Corporation to import the basic
classes of controlled substances is
consistent with the public interest and
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated March 9, 2007, and
published in the Federal Register on
March 23, 2007 (72 FR 13825), Sigma
Aldrich Research, Biochemicals, Inc., 1–
3 Strathmore Road, Natick,
Massachusetts 01760, made application
by letter to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
schedule I:
Drug
Psilocybin (7437) ..........................
5-Methoxy-N,Ndiisopropyltyptamine (7439).
Schedule
I
I
The company plans on manufacturing
reference standards for research
purposes only.
No comments or objections have been
received. DEA has considered the
factors in Title 21, United States Code
(U.S.C.) 823(a) and determined that the
registration of Sigma Aldrich Research,
Biochemicals, Inc. to manufacture the
listed basic class of controlled substance
is consistent with the public interest at
this time. DEA has investigated Sigma
Aldrich Research, Biochemicals, Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
E:\FR\FM\09AUN1.SGM
09AUN1
]]>Agencies
[Federal Register Volume 72, Number 153 (Thursday, August 9, 2007)]
[Notices]
[Page 44861]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-15515]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated May 10, 2007 and published in the Federal Register
on May 18, 2007, (72 FR 28077), Penick Corporation, 33 Industrial Park
Road, Pennsville, New Jersey 08070, made application by renewal to the
Drug Enforcement Administration (DEA) to be registered as an importer
of the basic classes of controlled substances listed in schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Coca Leaves (9040)......................... II
Raw Opium (9600)........................... II
Poppy Straw (9650)......................... II
Concentrate of Poppy Straw (9670).......... II
------------------------------------------------------------------------
The company plans to import the listed controlled substances to
manufacture bulk controlled substance intermediates for sale to its
customers.
No comments or objections have been received. DEA has considered
the factors in Title 21, United States Code (U.S.C.) Sec. 823(a) and
Sec. 952(a) and determined that the registration of Penick Corporation
to import the basic classes of controlled substances is consistent with
the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971, at this time. DEA has investigated Penick Corporation to ensure
that the company's registration is consistent with the public interest.
The investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to Title 21, U.S.C. 952(a) and 958(a), and
in accordance with Title 21, Code of Federal Regulations (CFR) Sec.
1301.34, the above named company is granted registration as an importer
of the basic classes of controlled substances listed.
Dated: July 31, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-15515 Filed 8-8-07; 8:45 am]
BILLING CODE 4410-09-P
